Fatal insomnia
Fatal insomnia is an extremely rare neurodegenerative prion disease that results in trouble sleeping as its hallmark symptom. The majority of cases are familial (fatal familial insomnia [FFI]), stemming from a mutation in the PRNP gene, with the remainder of cases occurring sporadically (sporadic fatal insomnia [sFI]). The problems with sleeping typically start out gradually and worsen over time. Eventually, the patient will succumb to total insomnia (agrypnia excitata), most often leading to other symptoms such as speech problems, coordination problems, and dementia. It results in death within a few months to a few years and has no known cure.
Fatal insomnia | |
---|---|
Cranial imaging of an FFI patient. In the MRI, there are abnormal signals in the bilateral frontoparietal subcortical area. MRA showed smaller distal branches of cerebral arteries. | |
Specialty | Neurology, Psychiatry, Sleep medicine, Neuropathology |
Symptoms | Progressive insomnia, ataxia, double vision, weight loss, high blood pressure, excessive sweating |
Complications | Permanent state of hypnagogia later in the illness |
Usual onset | 45–50 years old |
Types | Fatal familial insomnia, sporadic fatal insomnia |
Causes | Genetic mutation, sporadic form (very rare) |
Risk factors | Family history |
Diagnostic method | Suspected based on symptoms, supported by sleep study, PET scan and genetic testing (if familial form is suspected) |
Differential diagnosis | Alzheimer's disease, frontotemporal dementia, other transmissible spongiform encephalopathies |
Prevention | None |
Treatment | Supportive care |
Medication | None |
Prognosis | Always fatal |
Frequency | 70 families worldwide are known to carry the gene associated with the disease, 37 sporadic cases diagnosed (as of September 20th, 2022) |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.